{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:03:23Z","timestamp":1789369403267,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":33,"publisher":"Springer US","isbn-type":[{"value":"9781071654958","type":"print"},{"value":"9781071654965","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5496-5_12","type":"book-chapter","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:09:02Z","timestamp":1789366142000},"page":"125-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing Chikungunya Virus Protease Activity and Pharmacological Inhibition Using the acc-CHIK15-dnp Fluorogenic Peptide Substrate"],"prefix":"10.1007","author":[{"given":"Muhammad Arslan","family":"Rahat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sparsh","family":"Makhaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne A.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/0035-9203(55)90080-8","volume":"49","author":"MC Robinson","year":"1955","unstructured":"Robinson MC (1955) An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg 49:28\u201332. https:\/\/doi.org\/10.1016\/0035-9203(55)90080-8","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1017\/S0022172400044442","volume":"54","author":"RW Ross","year":"1956","unstructured":"Ross RW (1956) The Newala epidemic: III. The virus: isolation, pathogenic properties and relationship to the epidemic. Epidemiol Infect 54:177\u2013191. https:\/\/doi.org\/10.1017\/S0022172400044442","journal-title":"Epidemiol Infect"},{"key":"12_CR3","unstructured":"Chikungunya fact sheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chikungunya?utm_source=chatgpt.com. Accessed 21 Mar 2025"},{"key":"12_CR4","doi-asserted-by":"publisher","unstructured":"Higgs S, Vanlandingham D (2015) Chikungunya virus and its mosquito vectors. Vector-Borne Zoonotic Dis 15:231\u2013240. https:\/\/doi.org\/10.1089\/vbz.2014.1745","DOI":"10.1089\/vbz.2014.1745"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"e6835","DOI":"10.1371\/JOURNAL.PONE.0006835","volume":"4","author":"KA Tsetsarkin","year":"2009","unstructured":"Tsetsarkin KA, McGee CE, Volk SM et al (2009) Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes. PLoS One 4:e6835. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0006835","journal-title":"PLoS One"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"S436","DOI":"10.1093\/INFDIS\/JIW391","volume":"214","author":"H Zeller","year":"2016","unstructured":"Zeller H, Van Bortel W, Sudre B (2016) Chikungunya: its history in Africa and Asia and its spread to new regions in 2013\u20132014. J Infect Dis 214:S436\u2013S440. https:\/\/doi.org\/10.1093\/INFDIS\/JIW391","journal-title":"J Infect Dis"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/J.AMJMED.2019.10.005","volume":"133","author":"JK Amaral","year":"2020","unstructured":"Amaral JK, Bilsborrow JB, Schoen RT (2020) Chronic chikungunya arthritis and rheumatoid arthritis: what they have in common. Am J Med 133:e91\u2013e97. https:\/\/doi.org\/10.1016\/J.AMJMED.2019.10.005","journal-title":"Am J Med"},{"key":"12_CR8","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/JPIDS\/PIAE102","volume":"13","author":"FCPADM Ferreira","year":"2024","unstructured":"Ferreira FCPADM, Filippis AMBde, Moreira MEL et al (2024) Perinatal and neonatal chikungunya virus transmission: a case series. J Pediatric Infect Dis Soc 13:576\u2013584. https:\/\/doi.org\/10.1093\/JPIDS\/PIAE102","journal-title":"J Pediatric Infect Dis Soc"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/J.IJID.2023.11.036","volume":"139","author":"AS Sagay","year":"2024","unstructured":"Sagay AS, Hsieh SC, Dai YC et al (2024) Chikungunya virus antepartum transmission and abnormal infant outcomes in a cohort of pregnant women in Nigeria. Int J Infect Dis 139:92\u2013100.\u2002https:\/\/doi.org\/10.1016\/J.IJID.2023.11.036","journal-title":"Int J Infect Dis"},{"key":"12_CR10","unstructured":"VIMKUNYATM (Recombinant) | A Chikungunya Vaccine | For Travelers. https:\/\/vimkunya.com\/?gad_source=1&gad_campaignid=22505135260&gbraid=0AAAAA_c1E7jnRfbzbODcnwUwJtCTnV3k_&gclid=CjwKCAjwiNXFBhBKEiwAPSaPCZINvS8EPzqKRHb-92Cogmukq-K_OoKNQFFb7rXSxdgwmxy9Qtc_OhoCC78QAvD_BwE. Accessed 31 Aug 2025"},{"key":"12_CR11","unstructured":"For Healthcare Providers | IXCHIQ\u00ae (chikungunya vaccine, live) HCP. https:\/\/ixchiqhcp.com\/. Accessed 8 Apr 2025"},{"key":"12_CR12","unstructured":"FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live). FDA Suspends Biologics License: FDA Safety Communication | FDA. https:\/\/www.fda.gov\/safety\/medical-product-safety-information\/fda-update-safety-ixchiq-chikungunya-vaccine-live-fda-suspends-biologics-license-fda-safety. Accessed 12 Jan 2026"},{"key":"12_CR13","doi-asserted-by":"publisher","first-page":"e2124","DOI":"10.1371\/JOURNAL.PNTD.0002124","volume":"7","author":"SW Metz","year":"2013","unstructured":"Metz SW, Gardner J, Geertsema C et al (2013) Effective chikungunya virus-like particle vaccine produced in insect cells. PLoS Negl Trop Dis 7:e2124. https:\/\/doi.org\/10.1371\/JOURNAL.PNTD.0002124","journal-title":"PLoS Negl Trop Dis"},{"key":"12_CR14","doi-asserted-by":"crossref","unstructured":"Strauss JH, Strauss EG (1994) The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 58(3):491\u2013562","DOI":"10.1128\/mr.58.3.491-562.1994"},{"key":"12_CR15","doi-asserted-by":"publisher","first-page":"e22336","DOI":"10.1371\/JOURNAL.PONE.0022336","volume":"6","author":"YA Karpe","year":"2011","unstructured":"Karpe YA, Aher PP, Lole KS (2011) NTPase and 5\u2032-RNA triphosphatase activities of chikungunya virus nsP2 protein. PLoS One 6:e22336. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0022336","journal-title":"PLoS One"},{"key":"12_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/J.VIRUSRES.2007.09.009","volume":"131","author":"BAM Pastorino","year":"2008","unstructured":"Pastorino BAM, Peyrefitte CN, Almeras L et al (2008) Expression and biochemical characterization of nsP2 cysteine protease of Chikungunya virus. Virus Res 131:293\u2013298. https:\/\/doi.org\/10.1016\/J.VIRUSRES.2007.09.009","journal-title":"Virus Res"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1021\/ACSCHEMBIO.8B00508","volume":"13","author":"ME Hill","year":"2018","unstructured":"Hill ME, Kumar A, Wells JA et al (2018) The unique cofactor region of Zika virus NS2B-NS3 protease facilitates cleavage of key host proteins. ACS Chem Biol 13:2398\u20132405. https:\/\/doi.org\/10.1021\/ACSCHEMBIO.8B00508","journal-title":"ACS Chem Biol"},{"key":"12_CR18","doi-asserted-by":"publisher","unstructured":"Raj S, Irfan M, Ranjith-Kumar CT (2025) Chikungunya virus non-structural protein 2 (nsP2) inhibits RIG-I and TLR-mediated immune response. Virology 616:110777. https:\/\/doi.org\/10.1101\/2025.04.30.651505","DOI":"10.1101\/2025.04.30.651505"},{"key":"12_CR19","doi-asserted-by":"crossref","unstructured":"Boura\u00ef M, Lucas-Hourani M, Gad HH et al (2012) Mapping of chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral component. J Virol 86:3121\u20133134. https:\/\/doi.org\/10.1128\/JVI.06390-11","DOI":"10.1128\/JVI.06390-11"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"101159","DOI":"10.1016\/J.MAM.2022.101159","volume":"88","author":"T Majerov\u00e1","year":"2022","unstructured":"Majerov\u00e1 T, Konvalinka J (2022) Viral proteases as therapeutic targets. Mol Aspects Med 88:101159. https:\/\/doi.org\/10.1016\/J.MAM.2022.101159","journal-title":"Mol Aspects Med"},{"key":"12_CR21","doi-asserted-by":"publisher","unstructured":"Tompa DR, Immanuel A, Srikanth S, Kadhirvel S (2021) Trends and strategies to combat viral infections: a review on FDA approved antiviral drugs. Int J Biol Macromol 172:524\u2013541. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.01.076","DOI":"10.1016\/j.ijbiomac.2021.01.076"},{"key":"12_CR22","doi-asserted-by":"publisher","unstructured":"Bermejo H, Luis J, Pati\u00f1o C et al (2024) The design, synthesis and mechanism of action of paxlovid, a protease inhibitor drug combination for the treatment of COVID-19. Pharmaceutics 16:217. https:\/\/doi.org\/10.3390\/PHARMACEUTICS16020217","DOI":"10.3390\/PHARMACEUTICS16020217"},{"key":"12_CR23","doi-asserted-by":"publisher","first-page":"7382","DOI":"10.1128\/AAC.01421-16","volume":"60","author":"PK Das","year":"2016","unstructured":"Das PK, Puusepp L, Varghese FS et al (2016) Design and validation of novel chikungunya virus protease inhibitors. Antimicrob Agents Chemother 60:7382\u20137395. https:\/\/doi.org\/10.1128\/AAC.01421-16","journal-title":"Antimicrob Agents Chemother"},{"key":"12_CR24","doi-asserted-by":"publisher","unstructured":"Smith AJ, Rahat MA, Scaramozza LJ et al (2025) Inhibition of Zika virus protease by modulating NS2B-NS3 interactions. Biochemistry 65(1):64-76. https:\/\/doi.org\/10.1021\/acs.biochem.5c00644","DOI":"10.1021\/acs.biochem.5c00644"},{"key":"12_CR25","doi-asserted-by":"publisher","unstructured":"Makhaik S, Rut W, Choudhary S et al (2025) A robust fluorogenic substrate for chikungunya virus protease (nsP2) activity. Protein Sci 34. https:\/\/doi.org\/10.1002\/pro.70069","DOI":"10.1002\/pro.70069"},{"key":"12_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/J.BIOCHI.2018.04.004","volume":"149","author":"H Singh","year":"2018","unstructured":"Singh H, Mudgal R, Narwal M et al (2018) Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease. Biochimie 149:51\u201361. https:\/\/doi.org\/10.1016\/J.BIOCHI.2018.04.004","journal-title":"Biochimie"},{"key":"12_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/J.IJBIOMAC.2018.05.007","volume":"116","author":"M Narwal","year":"2018","unstructured":"Narwal M, Singh H, Pratap S et al (2018) Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site. Int J Biol Macromol 116:451\u2013462. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2018.05.007","journal-title":"Int J Biol Macromol"},{"key":"12_CR28","doi-asserted-by":"publisher","unstructured":"Rausalu K, Utt A, Quirin T et al (2016) Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease\u2019s active site cysteine residue. Sci Rep  6:37124. https:\/\/doi.org\/10.1038\/srep37124","DOI":"10.1038\/srep37124"},{"key":"12_CR29","doi-asserted-by":"publisher","unstructured":"Saisawang C, Sillapee P, Sinsirimongkol K et al (2015) Full length and protease domain activity of chikungunya virus nsP2 differ from other alphavirus nsP2 proteases in recognition of small peptide substrates. Biosci Rep 35(3):e00196. https:\/\/doi.org\/10.1042\/BSR20150086","DOI":"10.1042\/BSR20150086"},{"key":"12_CR30","doi-asserted-by":"publisher","unstructured":"Merten EM, Sears JD, Leisner TM, et al (2024) Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach. Proc Nat Acad Sci 121. https:\/\/doi.org\/10.1073\/pnas.2409166121","DOI":"10.1073\/pnas.2409166121"},{"key":"12_CR31","doi-asserted-by":"publisher","unstructured":"McGovern SL, Caselli E, Grigorieff N, Shoichet BK (2002) A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening. J Med Chem 45(8):1712\u20131722. https:\/\/doi.org\/10.1021\/jm010533y","DOI":"10.1021\/jm010533y"},{"key":"12_CR32","doi-asserted-by":"publisher","unstructured":"Dahlin JL, Nissink JWM, Strasser JM et al (2015) PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS. J Med Chem 58:2091\u20132113. https:\/\/doi.org\/10.1021\/JM5019093","DOI":"10.1021\/JM5019093"},{"key":"12_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1021\/ACSCHEMBIO.7B00903","volume":"13","author":"JB Baell","year":"2017","unstructured":"Baell JB, Nissink JWM (2017) Seven year itch: pan-assay interference compounds (pains) in 2017\u2014utility and limitations. ACS Chem Biol 13:36\u201344. https:\/\/doi.org\/10.1021\/ACSCHEMBIO.7B00903","journal-title":"ACS Chem Biol"}],"container-title":["Methods in Molecular Biology","Chikungunya Virus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5496-5_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:09:07Z","timestamp":1789366147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5496-5_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"ISBN":["9781071654958","9781071654965"],"references-count":33,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5496-5_12","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"15 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}